Detlev Riesner logo

Detlev Riesner

Description

Prof. Riesner has held the Chair of Biophysics at the Heinrich-Heine-University in Düsseldorf, Germany since 1980 and is Director of Technol...

Investor Profile

Detlev Riesner has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Manufacturing.

Stage Focus

  • Seed (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Manufacturing
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Detlev Riesner frequently co-invest with?

European Investment Fund
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 2
Evonik Venture Capital
Europe, Hessen, Germany, Hanau
Co-Investments: 1

Which angels does Detlev Riesner often collaborate with?

Shared Deals: 1

What are some of recent deals done by Detlev Riesner?

Pantherna Therapeutics

Hennigsdorf, Brandenburg, Germany

Pantherna Therapeutics is a privately-held biopharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics
SeedJul 3, 2019
Amount Raised: $3,950,976
Numaferm

Düsseldorf, Nordrhein-Westfalen, Germany

Numaferm is a Dusseldorf University spin-off that specializes in the biotechnical production.

BiotechnologyManufacturingPharmaceutical
SeedMay 13, 2017

Find More Investors Like Detlev Riesner

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Detlev Riesner | Pipeseed